BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37768032)

  • 1. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Catassi G; D'Arcangelo G; Norsa L; Bramuzzo M; Hojsak I; Kolho KL; Romano C; Gasparetto M; Di Giorgio A; Hussey S; Yerushalmy-Feler A; Turner D; Matar M; Weiss B; Karoliny A; Alvisi P; Tzivinikos C; Aloi M
    Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37768032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
    Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
    J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study.
    Wiecek S; Wojtyniak A; Pindur B; Machnikowska-Sokołowska M; Gruszczyńska K; Grzybowska-Chlebowczyk U
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34199130
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.
    Tenca A; Jaakkola T; Färkkilä M; Arola J; Kolho KL
    Scand J Gastroenterol; 2019 Aug; 54(8):984-990. PubMed ID: 31402720
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.
    Singh A; Midha V; Narang V; Kedia S; Mahajan R; Dhoble P; Kahlon BK; Dhaliwal AS; Tripathi A; Kalra S; Jain NP; Bansal N; Banerjee R; Desai D; Dutta U; Ahuja V; Sood A
    Intest Res; 2023 Oct; 21(4):452-459. PubMed ID: 36453008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very-early-onset inflammatory bowel disease versus late-onset inflammatory bowel disease in relation to clinical phenotype: A cross-sectional study.
    Mansour HH; Seddek SS; Meguid MEAEL; Eskander AE; Galal ST
    Indian J Gastroenterol; 2023 Apr; 42(2):185-191. PubMed ID: 37166697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children.
    Yoon J; Oh SH; Kim HJ; Park SH; Ye BD; Yang SK; Kim KM
    Pediatr Gastroenterol Hepatol Nutr; 2015 Dec; 18(4):268-75. PubMed ID: 26770902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment.
    Ricciuto A; Hansen BE; Ngo B; Aloi M; Walters TD; Church PC; Mazurek A; Khan M; Carman N; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1509-1517.e7. PubMed ID: 31493578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
    Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
    Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Fousekis FS; Theopistos VI; Mitselos IV; Skamnelos A; Kavvadias A; Katsanos KH; Christodoulou DK
    J Clin Med Res; 2019 Feb; 11(2):81-88. PubMed ID: 30700999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.